OG
Orbit Genomics, Inc.
SEC filingBiotechnology · Boulder, CO
Amount raised$780Ksold at filing
Total offering$2M$1.2M still open
Investors in the raise15count reported to the SEC
FiledJul 28, 2025first sale Jul 29, 2024
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Oerum N MikaelDirector
Harold (Skip) N GarnerExecutive Officer, Director
Elizabeth (Dede) N WillisExecutive Officer, Director
Julie N SilberDirector
Executive officers, directors and promoters as listed on the Form D.